Bank of America’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $430K | Sell |
1,035,127
-416,651
| -29% | -$173K | ﹤0.01% | 4884 |
|
|
2025
Q1 | $904K | Buy |
1,451,778
+416,452
| +40% | +$259K | ﹤0.01% | 4414 |
|
|
2024
Q4 | $1.73M | Buy |
1,035,326
+860,703
| +493% | +$1.44M | ﹤0.01% | 3860 |
|
|
2024
Q3 | $318K | Buy |
174,623
+133,613
| +326% | +$243K | ﹤0.01% | 4923 |
|
|
2024
Q2 | $247K | Sell |
41,010
-6,145
| -13% | -$37.1K | ﹤0.01% | 4973 |
|
|
2024
Q1 | $526K | Sell |
47,155
-17,601
| -27% | -$196K | ﹤0.01% | 4527 |
|
|
2023
Q4 | $964K | Buy |
64,756
+13,008
| +25% | +$194K | ﹤0.01% | 4168 |
|
|
2023
Q3 | $248K | Buy |
51,748
+24,447
| +90% | +$117K | ﹤0.01% | 4913 |
|
|
2023
Q2 | $205K | Buy |
27,301
+1,896
| +7% | +$14.2K | ﹤0.01% | 4984 |
|
|
2023
Q1 | $115K | Sell |
25,405
-177,669
| -87% | -$803K | ﹤0.01% | 5409 |
|
|
2022
Q4 | $2.29M | Buy |
203,074
+180,868
| +815% | +$2.04M | ﹤0.01% | 3557 |
|
|
2022
Q3 | $213K | Buy |
22,206
+5,332
| +32% | +$51.1K | ﹤0.01% | 5147 |
|
|
2022
Q2 | $136K | Sell |
16,874
-41,807
| -71% | -$337K | ﹤0.01% | 5550 |
|
|
2022
Q1 | $992K | Sell |
58,681
-10,644
| -15% | -$180K | ﹤0.01% | 4603 |
|
|
2021
Q4 | $1.49M | Buy |
69,325
+62,419
| +904% | +$1.34M | ﹤0.01% | 4164 |
|
|
2021
Q3 | $509K | Buy |
6,906
+999
| +17% | +$73.6K | ﹤0.01% | 4835 |
|
|
2021
Q2 | $323K | Buy |
5,907
+2,732
| +86% | +$149K | ﹤0.01% | 5010 |
|
|
2021
Q1 | $233K | Sell |
3,175
-3,935
| -55% | -$289K | ﹤0.01% | 5270 |
|
|
2020
Q4 | $613K | Sell |
7,110
-1,400
| -16% | -$121K | ﹤0.01% | 4188 |
|
|
2020
Q3 | $321K | Buy |
+8,510
| New | +$321K | ﹤0.01% | 4431 |
|